EUVIMED · CrossrefZeitschrift
Klinická farmakologie a farmacie
ISSN 1212-7973 · Solen s.r.o.
Neueste Artikel
Pharmacovigilance: a pillar of safe pharmacotherapy and its importance in clinical practice
Obesity treatment with incretin-based therapies
Magnesium and sexual health: biological mechanisms, clinical evidence and practical implications
Current options in insulin pump therapy for diabetes
Gliflozins in the treatment of diabetes and its complications
Current options in insulin therapy
Genotype-phenotype correlation of CYP2C19: phenoconversion, population-specific characteristics, and modern sequencing approaches in personalised pharmacotherapy
Cefiderocol in the treatment of infectious complications caused by a multidrug-resistant strain of Acinetobacter baumannii in a patient with severe burns
Targeted treatment of psoriatic arthritis
Interactions between ARTA drugs and orally administered anticoagulants
The significant role of gliflozins in the treatment of type 2 diabetes mellitus
The microbiome and pharmacotherapy: from mechanisms to consequences
QT interval, etiopathogenesis of "torsade de pointes", and risk pharmacotherapy
Methadone poisoning in a child
Biological treatment of asthma at the end of the first quarter of the 21st century
Allergen immunotherapy for respiratory allergies
Injectable and non-injectable adrenaline applicators - their use in practice
Allergic rhinitis - allergist's point of view
Adverse effects of oral anticoagulant therapy in hospitalized patients
Beta-blockers in acute coronary syndrome: current evidence and clinical implications
Beta-blockers in the treatment of chronic coronary artery disease
Beta-blockers in the treatment of arterial hypertension
Betablockers in the treatment of heart rhythm disorders
Beta-blockers in the treatment of heart failure
Treatment of multimorbid patients with multiple sclerosis
Nitazenes and other opioid receptor superagonists
Efficacy and safety of fezolinetant in the treatment of moderate to severe vasomotor symptoms in women for whom hormone therapy is considered inappropriate
Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition
Pharmacokinetic drug-drug interactions of direct oral anticoagulants
Drug-drug interactions of DOAC and anticonvulsants
EUVIMED